As of Jun 24
| -0.53 / -5.99%|
The 6 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 15.75, with a high estimate of 34.00 and a low estimate of 12.00. The median estimate represents a +89.30% increase from the last price of 8.32.
The current consensus among 6 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.